Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Maxwell

Showing results (541-550 of 563) with videos related to

Pageof 57
Sort By:
Gynecologic Oncology|December 3, 2017
Clinicopathologic characteristics associated with long-term survival in advanced epithelial ovarian cancer: an NRG Oncology/Gynecologic Oncology Group ancillary data studyC A Hamilton, A Miller, Y Casablanca, et al.
Child Development|March 27, 2007
Teachers' education, classroom quality, and young children's academic skills: results from seven studies of preschool programsDiane M Early, Kelly L Maxwell, Margaret Burchinal, et al.
Cancers|March 25, 2022
Molecular Correlates of Venous Thromboembolism (VTE) in Ovarian CancerDeanna Glassman, Nicholas W Bateman, Sanghoon Lee, et al.
Cancers|May 28, 2022
Whole-Genome Sequencing Identifies <i>PPARGC1A</i> as a Putative Modifier of Cancer Risk in <i>BRCA1/2</i> Mutation CarriersQianqian Zhu, Jie Wang, Han Yu, et al.
Nature Structural Biology|October 4, 2000
Structural proteomics of an archaeonD Christendat, A Yee, A Dharamsi, et al.
Journal for Immunotherapy of Cancer|June 22, 2019
Efficient identification of neoantigen-specific T-cell responses in advanced human ovarian cancerSong Liu, Junko Matsuzaki, Lei Wei, et al.
Gynecologic Oncology|February 10, 2021
Clinical significance of homologous recombination deficiency score testing in endometrial CancerJean H Siedel, Kari L Ring, Wei Hu, et al.
Oncotarget|November 17, 2016
Interim analysis of a phase I/IIa trial assessing E39+GM-CSF, a folate binding protein vaccine, to prevent recurrence in ovarian and endometrial cancer patientsDoreen O Jackson, Kevin Byrd, Timothy J Vreeland, et al.
Clinical Pharmacology and Therapeutics|March 7, 2019
From Discovery to Practice and Survivorship: Building a National Real-World Data Learning Healthcare Framework for Military and Veteran Cancer PatientsJerry S H Lee, Kathleen M Darcy, Hai Hu, et al.
Conservation Biology : the Journal of the Society for Conservation Biology|November 25, 2022
Retaining natural vegetation to safeguard biodiversity and humanityJeremy S Simmonds, Andres Felipe Suarez-Castro, April E Reside, et al.
Pageof 57

Showing results (541-550 of 563) with videos related to

Sort By:
Pageof 57
Gynecologic Oncology|December 3, 2017
Clinicopathologic characteristics associated with long-term survival in advanced epithelial ovarian cancer: an NRG Oncology/Gynecologic Oncology Group ancillary data studyC A Hamilton, A Miller, Y Casablanca, et al.
Child Development|March 27, 2007
Teachers' education, classroom quality, and young children's academic skills: results from seven studies of preschool programsDiane M Early, Kelly L Maxwell, Margaret Burchinal, et al.
Cancers|March 25, 2022
Molecular Correlates of Venous Thromboembolism (VTE) in Ovarian CancerDeanna Glassman, Nicholas W Bateman, Sanghoon Lee, et al.
Cancers|May 28, 2022
Whole-Genome Sequencing Identifies <i>PPARGC1A</i> as a Putative Modifier of Cancer Risk in <i>BRCA1/2</i> Mutation CarriersQianqian Zhu, Jie Wang, Han Yu, et al.
Nature Structural Biology|October 4, 2000
Structural proteomics of an archaeonD Christendat, A Yee, A Dharamsi, et al.
Journal for Immunotherapy of Cancer|June 22, 2019
Efficient identification of neoantigen-specific T-cell responses in advanced human ovarian cancerSong Liu, Junko Matsuzaki, Lei Wei, et al.
Gynecologic Oncology|February 10, 2021
Clinical significance of homologous recombination deficiency score testing in endometrial CancerJean H Siedel, Kari L Ring, Wei Hu, et al.
Oncotarget|November 17, 2016
Interim analysis of a phase I/IIa trial assessing E39+GM-CSF, a folate binding protein vaccine, to prevent recurrence in ovarian and endometrial cancer patientsDoreen O Jackson, Kevin Byrd, Timothy J Vreeland, et al.
Clinical Pharmacology and Therapeutics|March 7, 2019
From Discovery to Practice and Survivorship: Building a National Real-World Data Learning Healthcare Framework for Military and Veteran Cancer PatientsJerry S H Lee, Kathleen M Darcy, Hai Hu, et al.
Conservation Biology : the Journal of the Society for Conservation Biology|November 25, 2022
Retaining natural vegetation to safeguard biodiversity and humanityJeremy S Simmonds, Andres Felipe Suarez-Castro, April E Reside, et al.
Pageof 57